Immutep Limited (IMMP) Stock price, Description, News & Info

#Thinksabio latest news

Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025